Michelle S. Bloom

Natera (United States) — United States

Medicine · Health Sciences

17h-index1.2kcitations46works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Transplantation Outcomes and Treatments(7), Renal Diseases and Glomerulopathies(6), Renal and related cancers(6), Genomics and Chromatin Dynamics(5), Systemic Lupus Erythematosus Research(5)

Publications46 total

Donor-Derived Cell-Free DNA in Pancreas-Kidney, Heart-Kidney, and Liver-Kidney Multiorgan Transplant Recipients (MOTR)
Transplant International·2026Open Access
Assessing the Protective Effects of the N264K Variant (M1) in APOL1-Mediated Kidney Disease in a Real-World CKD Population
Journal of the American Society of Nephrology·2025
Complexities in Variant Analysis, Classification, and Interpretation in Kidney Disease–Related Genes
Seminars in Nephrology·2025Open Access
Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study
American Journal of Transplantation·2025· 3 citedOpen Access
Severe Pulmonary Hypertension Secondary to Pulmonary Artery Compression With Resolution Following Hodgkin Lymphoma Therapy
JACC Case Reports·2025Open Access
A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation
American Journal of Transplantation·2025· 8 citedOpen Access
Outcomes of patients with cancer admitted with heart failure–associated cardiogenic shock
European Heart Journal Acute Cardiovascular Care·2025· 2 cited
Risk of Post‐Transplant Malignancy After Isolated Heart Transplant Among Adult Patients With Congenital Heart Disease
Clinical Transplantation·2025· 2 cited
Prevention, screening, and surveillance in cardio-oncology
Elsevier eBooks·2025
Abstract 4118018: Increased Risk of Post-Transplant Malignancy After Isolated Heart Transplant in Adult Patients with Congenital Heart Disease
Circulation·2024
Assessment of Key Indicators of Pathogenicity in PKD1/2 Variants
Journal of the American Society of Nephrology·2024
Results of Genetic Testing with a 385-Gene Panel in African American Patients with Kidney Diseases
Journal of the American Society of Nephrology·2024
Genetic Landscape of Glomerular Diseases and FSGS among More than 50,000 People Genetically Tested for CKD
Journal of the American Society of Nephrology·2024
Heterozygous loss of function variants in <scp><i>IFT140</i></scp> are associated with polycystic kidney disease
American Journal of Medical Genetics Part A·2024· 5 citedOpen Access
Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant
Transplantation·2024· 34 citedOpen Access
Townes-Brocks Syndrome Revealed by Kidney Gene Panel Testing
Kidney International Reports·2024· 4 citedOpen Access
Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis
JCI Insight·2024· 9 citedOpen Access
Use of Donor-derived Cell-free DNA to Inform Tapering of Immunosuppression Therapy in Kidney Transplant Recipients: An Observational Study
Transplantation Direct·2024· 10 citedOpen Access
Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis
Nature Communications·2023· 24 citedOpen Access
“Genotype-First” Approach to Analyzing the Diversity and Prevalence of Genes in a Cohort of Cystic Disease Patients
Journal of the American Society of Nephrology·2023
page 1 of 3Next →

Frequent Co-authors

William H. Robinson(16), Hossein Tabriziani(10), Heidi Wong(9), Sumit Punj(9), Zachary Demko(8), Dinah Clark(6), Kevin D. Deane(5), V. Michael Holers(5), Harini Raghu(5), Nithya Lingampalli(5), Constance R. Chu(5), Jeremy Sokolove(5), Philippe Gauthier(5), Nour Al Haj Baddar(5), Jennifer Seifert(4), M. Kristen Demoruelle(4), Qian Wang(4), Nick Hu(4), Eileen E Elliott(4), Nicholas J. Giori(4)